Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 45Terminated 13Unknown 12Recruiting 11Withdrawn 9Active not recruiting 5Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 2Thoracic 1Genitourinary 1Classical hematology 1

Conditions

Glioblastoma 2Urinary Bladder Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anemia 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Ascorbic Acid × Clear all
NCT02905591 2026-03-25

XACT-LUNG

University of Iowa

Phase 2 Active not recruiting
43 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02344355 2025-12-12

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

University of Iowa

Phase 2 Active not recruiting
90 enrolled
CNS

Glioblastoma

NCT04900792 2025-12-03

XACT-Fe-GBM-01

University of Iowa

Phase 1 Active not recruiting
17 enrolled
CNS

Glioblastoma

NCT06018883 2025-08-07

PTCA199-3

Fudan University

Phase 3 Active not recruiting
100 enrolled
Classical hematology

Anemia

NCT04046094 2025-03-25

Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients

University of Kansas Medical Center

Phase 1/2 Active not recruiting
12 enrolled 9 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡